Correction Volume 15, Issue 12 pp 5951—5953

Correction for: Efficacy and safety of recombinant human follicle-stimulating hormone in patients undergoing in vitro fertilization-embryo transfer

Linli Hu1, , Songying Zhang2, , Song Quan3, , Jieqiang Lv4, , Weiping Qian5, , Yuanhua Huang6, , Weiying Lu6, , Yingpu Sun1, ,

  • 1 The First Affiliated Hospital of Zhengzhou University, Reproductive Medicine, Zhengzhou, China
  • 2 Sir Run Run Shaw Hospital of Zhejiang University, Reproductive Medicine, Hangzhou, China
  • 3 Southern Medical University, Reproductive Medicine, Guangzhou, China
  • 4 Second Affiliated Hospital of Wenzhou Medical University, Reproductive Medicine, Wenzhou, China
  • 5 Peking University Shenzhen Hospital, Reproductive Medicine, Shenzhen, China
  • 6 Hainan Medical College, Reproductive Medicine, Haikou, China

Received: March 27, 2023       Accepted: June 20, 2023       Published: June 29, 2023      

https://doi.org/10.18632/aging.204490
How to Cite
Correction for: Aging (Albany NY). 2020; 12:4918-4930 . https://doi.org/10.18632/aging.102919  PMID: 32209728

Copyright: © 2023 Hu et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.